> Contact
> Homepage
> Site map
> Links

About HIFU
About Ablatherm
Clinical Information
Clinical Results
Clinical Trials


Published Abstracts
& Articles
Video Clips
 You are here : Physicians > HIFU - Ablatherm



HIFU treatment with Ablatherm is a treatment option for localized prostate cancer, with the best risk-benefit ratio, that is setting a high standard of care for Prostate cancer patients.

The less invasive option available today

Many patients cannot tolerate the side effects associated with radiation. Additionally, not all prostate cancer patients can or want to undergo surgery. For these patients Ablatherm offers an excellent alternative.
Non-Invasive: no port, no seeds, no incision, no radiation
Effective: precise and definitive necrosis of the targeted area
Early Feedback: nadir PSA after only 3 months
Quality of Life: minimal side effects
Repeatable: if needed at any time during follow up
Adaptable: to the physician and the patient ’s therapeutic goals
No Therapeutic impasse : alternative options still open post Ablatherm
Cost effective : short hospitalization and minimal recuperation time.

Proven results

With more than ten years follow-up, and thousands of patients treated, HIFU with Ablatherm has emerged as the most promising amongst minimally invasive treatment options for localized prostate cancer available today.

Availability

The interest of the urological community for this new treatment is now rapidly increasing. Urologists widely accept that Ablatherm is the non invasive alternative treatment for localized prostate cancer. Furthermore, mobile machines enable all hospitals whatever their activities or financial means, to have access to this new therapeutic alternative.

centres in Europe Evolution of the number of centres using Ablatherm HIFU in Europe since 2001.
Treatments per year Evolution of the number of patients treated with Ablatherm HIFU since 1993

To see where Ablatherm HIFU is now available please CLICK HERE.

world map

Why wait ?

With a short hospital stay and almost immediate patient recovery, with the best risk-benefit ratio in this indication and the possibility of repeating the treatment, Ablatherm is a very attractive choice for prostate cancer patients.

This section of our website is designed to introduce you to the HIFU technology with Ablatherm. Should you have any questions, request additional information, or a visit from a sales representative, please contact us.

Click here for more information on Edap-TMS

® Ablatherm is aregistered trademark of EDAP.
© Copyright 2007 EDAP. All rights reserved.